PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker. A Purdue University-affiliated artificial intelligence company, PhysIQ’s AI-based COVID-19 digital biomarker is being developed to address the rapid decompensation of high-risk COVID-19 patients, according to a news release. PhysIQ’s technology’s cloud platform continuously […]
Funding Roundup
Senseonics announces $50M from stock offering
Senseonics (NYSE:SENS) announced that it entered into securities purchase agreements worth gross proceeds of approximately $50 million. Germantown, Md.-based Senseonics’ purchase agreements are with several healthcare-focused investors, as well as other institutional investors, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
MedTech 100 roundup: Finally a dip as industry stays relatively strong
After three consecutive weeks of record-breaking numbers, medtech industry stocks finally fell backward over the past seven days. MassDevice‘s MedTech 100 index finished last week at 105.8 (Jan. 15), marking a -0.95% drop from the 106.81 points (the highest ever total for the index) registered at the end of the week prior (Jan. 8). Medtech’s […]
These medtech stocks performed the best in 2020
While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]
TransEnterix raises more than $31M in stock offering
TransEnterix (NYSE:TRXC) announced today that it has raised $31.25 million from several institutional investors in a direct offering of common stock. The offering involves the sale of 25 million shares of TransEnterix common stock at a purchase price of $1.25 per share. The surgical robotics company plans to use the funds for general corporate purposes, including […]
Pavmed closes $12.4m offering
Pavmed (NSDQ:PAVM) announced last week that it closed a registered direct offering of common stock shares worth $12.4 million. New York-based Pavmed’s previously announced offering included 6 million shares of common stock at a price of $2.24 per share, priced at-the-market under Nasdaq rules, according to a news release. The company estimates that the net proceeds […]
MedTech 100 roundup: Industry skyrockets as hot streak continues
The medtech industry’s seemingly unstoppable rise over the past several weeks shows no signs of slowing down. For the fourth time in five weeks, and for the third consecutive week, the MassDevice MedTech 100 Index — which includes stocks of the world’s largest medical device companies — hit an all-time high. Previous highs have largely been […]
Ablacon raises $30m in Series B fundraising round
Ajax Health-backed Ablacon announced that it closed a Series B financing round worth $30 million with a new lead investor. Zeus Health joined as the new lead investor in the financing, while the company announced that Beaumont Health (Royal Oak, Mich.) Heart Rhythm Center director Dr. David Haines was appointed to Ablacon’s scientific advisory board, […]
Volta Medical raises $28M for Afib treatment tech
Volta Medical announced this week that it raised $28 million in a financing round for its AI algorithms for treating cardiac arrhythmias. Marseille, France-based Volta Medical said in a news release that the $28 million, raised in a round led by Gilde Healthcare with participation from existing shareholder Pasteur Mutualité, will help the company establish […]
Lungpacer Medical raises nearly $16M
Lungpacer Medical filed an SEC Form D earlier this week to confirm the sale of nearly $16 million in an equity financing. Vancouver, Canada-based Lungpacer develops a diaphragm pacing therapy system (DPTS) to assist in weaning patients off mechanical ventilation who are determined by a healthcare provider to be at high risk of weaning failure. […]
CorWave raises $40m in funding for breakthrough heart pump
CorWave announced today that it raised $40 million from a mix of returning and new investors for its wave membrane heart pump. Clichy, France-based CorWave received funding — from three new investors joining its returning investors — which is earmarked for its implantable left ventricular assist device (LVAD) which uses its breakthrough wave membrane pump […]
